March 25, 2008 - BioReliance Corporation has established a commercial office in Tokyo, expanding its operations to significantly address the growth opportunities in the Asia Pacific markets.
Click here for more details in English.
Click here for more details in Japanese.

David L. Bellitt joins Bioreliance
David L. Bellitt has been named Vice President of Global Commercial Operations, Biologics. Mr. Bellitt will be responsible for all global commercialization activities, including sales, marketing and customer service. He will also serve as a member of the Corporate Operating Committee.
Click here to read the press release.